Medicare FFS ophthalmology
Provider service volume comparison
Compare two ophthalmology providers by CY2023 Medicare FFS service volume and CPT/HCPCS mix.
Charles M Gremillion, MD
NPI 1871572164 | Englewood, FL
- National rank
- #4
- Total services
- 336,207
Choose provider
No provider selected.
Search providersCPT/HCPCS service volume comparison
Rows compare visible public provider-service lines by Medicare FFS service count.
| CPT/HCPCS | Description | Provider A services | Provider B services | Absolute difference | Higher Medicare FFS service volume |
|---|---|---|---|---|---|
| J2403 | Chloroprocaine hcl ophthalmic, 3% gel, 1 mg | 268,000 | 0 | 268,000 | Provider A higher |
| J2777 | Injection, faricimab-svoa, 0.1 mg | 47,160 | 0 | 47,160 | Provider A higher |
| 92134 | Imaging of retina | 4,728 | 0 | 4,728 | Provider A higher |
| 67028 | Injection of drug into eye | 2,441 | 0 | 2,441 | Provider A higher |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | 2,237 | 0 | 2,237 | Provider A higher |
| 92250 | Photography of the retina | 2,157 | 0 | 2,157 | Provider A higher |
| J2781 | Injection, pegcetacoplan, intravitreal, 1 mg | 1,710 | 0 | 1,710 | Provider A higher |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | 1,674 | 0 | 1,674 | Provider A higher |
| J0178 | Injection, aflibercept, 1 mg | 1,568 | 0 | 1,568 | Provider A higher |
| J2778 | Injection, ranibizumab, 0.1 mg | 1,119 | 0 | 1,119 | Provider A higher |
| Q5128 | Injection, ranibizumab-eqrn (cimerli), biosimilar, 0.1 mg | 768 | 0 | 768 | Provider A higher |
| J3490 | Unclassified drugs | 634 | 0 | 634 | Provider A higher |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | 347 | 0 | 347 | Provider A higher |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg | 266 | 0 | 266 | Provider A higher |
| 92202 | Extended exam of the back part of the eye with optic nerve drawing | 155 | 0 | 155 | Provider A higher |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 128 | 0 | 128 | Provider A higher |
| 92201 | Extended exam of the back part of the eye with retinal drawing | 76 | 0 | 76 | Provider A higher |
| 76512 | 2d ultrasound scan of eye tissue and structures | 58 | 0 | 58 | Provider A higher |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | 54 | 0 | 54 | Provider A higher |
| 67042 | Removal of membrane of retina with removal of internal limiting membrane of retina | 38 | 0 | 38 | Provider A higher |
| 66821 | Removal of recurring cataract in lens capsule using a laser | 32 | 0 | 32 | Provider A higher |
| 67036 | Removal of eye fluid (vitreous) between lens and retina | 30 | 0 | 30 | Provider A higher |
| 67515 | Injection of drug or substance into membrane covering eyeball | 29 | 0 | 29 | Provider A higher |
| 67210 | Destruction of growth of retina using a laser | 17 | 0 | 17 | Provider A higher |
| 92235 | Exam of retinal blood vessels using a special camera after injection of a dye | 17 | 0 | 17 | Provider A higher |
| 67141 | Heat or freezing treatment to prevent detachment of retina | 12 | 0 | 12 | Provider A higher |
| J0713 | Injection, ceftazidime, per 500 mg | 11 | 0 | 11 | Provider A higher |
| J3370 | Injection, vancomycin hcl, 500 mg | 11 | 0 | 11 | Provider A higher |